Lineage Cell Therapeutics, Inc. Capital Leases, Future Minimum Payments Due in Three Years
Lineage Cell Therapeutics, Inc. (LCTX) had Capital Leases, Future Minimum Payments Due in Three Years of $36.00 thousand as of 2019-03-31, per its 10-Q filed 2019-05-09.
Discontinued › Notes › Leases
us-gaap:CapitalLeasesFutureMinimumPaymentsDueInThreeYears · last filed 2019-05-09
- 2019-03-31: Capital Leases, Future Minimum Payments Due in Three Years $36.00K.
- 2018-12-31: Capital Leases, Future Minimum Payments Due in Three Years $36.00K.
- 2017-12-31: Capital Leases, Future Minimum Payments Due in Three Years $37.00K.
- 2016-12-31: Capital Leases, Future Minimum Payments Due in Three Years $93.00K.
| Period end | Capital Leases, Future Minimum Payments Due in Three Years |
|---|---|
| 2019-03-31 | $36.00K 10-Q · filed 2019-05-09 |
| 2018-12-31 | $36.00K 10-K · filed 2019-03-14 |
| 2017-12-31 | $37.00K 10-K · filed 2018-03-15 |
| 2016-12-31 | $93.00K 10-K · filed 2017-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| PALISADE BIO, INC. (PALI) | United States | $0.275B | -11.41 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |